Zentalis Pharmaceuticals
(NASDAQ:ZNTL)
$19.75
At close: Dec 8(Delayed 15-Minutes)
Get Real Time Here
$19.75
PreMarket: 4:00PM EDT
Day Range- - -52 Wk Range17.330 - 85.950Open / Close- / -Float / Outstanding41.921M / 57.069M
Vol / Avg.0 / 581.621KMkt Cap1.127BP/E-50d Avg. Price22.220
Div / Yield (Forward)- / -%Payout Ratio-Total Float41.921MEPS-4.690

Zentalis Pharmaceuticals Stock (NASDAQ:ZNTL), Quotes and News Summary

Zentalis Pharmaceuticals Stock (NASDAQ: ZNTL) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range17.330 - 85.950Open / Close- / -Float / Outstanding41.921M / 57.069M
Vol / Avg.0 / 581.621KMkt Cap1.127BP/E-50d Avg. Price22.220
Div / Yield (Forward)- / -%Payout Ratio-Total Float41.921MEPS-4.690
Seeking Alpha - May 16, 2022, 10:00AM
Sector: Health Care.Industry: Biotechnology
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-23
REV
Q3 2022Est.ActualSurprise
EPS-1.170-0.960 0.2100
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Zentalis Pharmaceuticals (ZNTL) stock?

A

You can purchase shares of Zentalis Pharmaceuticals (NASDAQ: ZNTL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Zentalis Pharmaceuticals's (ZNTL) competitors?

Q

What is the target price for Zentalis Pharmaceuticals (ZNTL) stock?

A

The latest price target for Zentalis Pharmaceuticals (NASDAQ: ZNTL) was reported by Wedbush on Monday, November 14, 2022. The analyst firm set a price target for 32.00 expecting ZNTL to rise to within 12 months (a possible 62.03% upside). 14 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Zentalis Pharmaceuticals (ZNTL)?

A

The stock price for Zentalis Pharmaceuticals (NASDAQ: ZNTL) is $19.75 last updated December 8, 2022, 9:00 PM UTC.

Q

Does Zentalis Pharmaceuticals (ZNTL) pay a dividend?

A

There are no upcoming dividends for Zentalis Pharmaceuticals.

Q

When is Zentalis Pharmaceuticals (NASDAQ:ZNTL) reporting earnings?

A

Zentalis Pharmaceuticals’s Q4 earnings are confirmed for Thursday, February 23, 2023.

Q

Is Zentalis Pharmaceuticals (ZNTL) going to split?

A

There is no upcoming split for Zentalis Pharmaceuticals.

Q

What sector and industry does Zentalis Pharmaceuticals (ZNTL) operate in?

A

Zentalis Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.